CAJ | 학술논문

目的：分析急性心肌梗死患者入院时糖化血红蛋白（HbA1 c）和血糖水平与接受经皮冠状动脉介入治疗（PCI）后预后水平的关系。方法回顾性分析120例接受PCI治疗的急性心肌梗死患者的临床资料，将患者依据是否出现HbA1 c增高分为增高组（A组）与对照组（B组）。对比2组患者的一般资料、临床疗效以及心血管不良事件发生率。结果2组患者除糖尿病发生率外一般资料差异无统计学意义（P＞0.05）。增高组患者治疗后K illip分级显著高于对照组（ P＜0.05），增高组患者左心房内径、左室射血分数、左室舒张期内径与对照组差异存在统计学意义（P＜0.05或 P＜0.01）。增高组患者的再发心肌梗死和频发室性期前收缩发生率显著高于对照组（P＜0.05）。结论入院时HbA1c升高对于急性心肌梗死患者的预后以及心血管不良事件发生率具有显著影响。
목적：분석급성심기경사환자입원시당화혈홍단백（HbA1 c）화혈당수평여접수경피관상동맥개입치료（PCI）후예후수평적관계。방법회고성분석120례접수PCI치료적급성심기경사환자적림상자료，장환자의거시부출현HbA1 c증고분위증고조（A조）여대조조（B조）。대비2조환자적일반자료、림상료효이급심혈관불량사건발생솔。결과2조환자제당뇨병발생솔외일반자료차이무통계학의의（P＞0.05）。증고조환자치료후K illip분급현저고우대조조（ P＜0.05），증고조환자좌심방내경、좌실사혈분수、좌실서장기내경여대조조차이존재통계학의의（P＜0.05혹 P＜0.01）。증고조환자적재발심기경사화빈발실성기전수축발생솔현저고우대조조（P＜0.05）。결론입원시HbA1c승고대우급성심기경사환자적예후이급심혈관불량사건발생솔구유현저영향。
Objective To investigate the relationship between plasma HbA1c and prognosis in acute myocar‐dial infarction patients undergoing percutaneous coronary intervention .Methods A total of 120 acute myocardial infarction patients undergoing percutaneous coronary intervention were divided into two groups ,patients with higher plasma HbA1 c level as group A and patients with normal plasma HbA1 c level as group B .The general da‐ta ,prognosis and incidence of cardiovascular adverse events were compared between two groups .Results There was no significant difference of general data ,except diabetes rate (P>0.05) .The Killip in group A was signifi‐cantly higher than that in group B after treatment (P<0 .05) .There was a significant difference of LA ,LVDd and LVEF between group A and group B (P<0 .05 ,P<0 .01) .The recurrent and premature ventricular contrac‐tion rates in group A were significantly less than those in group B .Conclusion Plasma HbA1 c level has a signifi‐cant influence on the prognosis and cardiovascular adverse events of PCI treatment patients .